Dr. Ketki Krishnakumar Tendulkar, MD

Dr. Tendulkar practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Tendulkar's NPI, 1962521062, was assigned on March 28, 2007. Dr. Tendulkar holds Nebraska license 25138.

Dr. Tendulkar's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Tendulkar also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Tendulkar's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. Tendulkar is also affiliated with Bellevue Medical Center. The medical group on file is UNMC Physicians. Dmand AI also links Dr. Tendulkar to 1 more dialysis center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tendulkar practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Tendulkar's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Tendulkar is licensed in Nebraska.

CMS data shows 177 Medicare services from Dr. Tendulkar across 6 procedure codes in 2024, for 128 Medicare patients. Medicare paid $11,832 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 128 Medicare patients who saw Dr. Tendulkar in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 18% are also on Medicaid. Their average risk score is 3.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tendulkar's median patient age at 72, with 54% women.

In 2024, Dr. Tendulkar wrote 650 Medicare Part D claims for 92 patients. 80% of them were for generic drugs. CMS names the drug for 470 of them, across 16 drugs with 11 or more claims each, at $56,885 in total drug cost. In 2023, CMS named 532 claims across 16 drugs.

Dr. Tendulkar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tendulkar as offering telehealth.

Dmand AI links 9 papers to Dr. Tendulkar, published from 2011 to 2024. The most frequent topics are Kidney and Kidney Diseases. Dr. Tendulkar's most frequent co-authors are Vijaya Raj Bhatt, MD, Anum Abbas, MBBS and Nathan Christopher Birch, MD.

CMS Open Payments shows 2 general payments to Dr. Tendulkar from 2 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 100% of the total. Alexion Pharmaceuticals, Inc. paid the most, $116.